Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Drugs for Lung Cancer

Abraxane for Injectable Suspension (paclitaxel proteinbound particles for injectable suspension) or (albumin-bound) for intravenous use

Drug company: Bristol Myers Squibb
800-861-0048

Bristol Myers Squibb Access Support offers 2 financial assistance programs for patients using Abraxane:

BMS Oncology Co‑Pay Assistance Program

Bristol Myers Squibb Patient Assistance Foundation

Alecensa (alectinib) Capsules

Drug company: Genentech
866-422-2377

Genentech Oncology offers 2 financial assistance programs for patients using Alecensa:

Genentech Oncology Co-pay Assistance Program

Genentech Patient Foundation

Alimta (pemetrexed) Injection

Drug company: Eli Lilly
866-472-8663

Lilly Oncology offers 2 financial assistance programs for patients using Alimta:

Lilly Oncology Infused Products Co-pay Program

Lilly Cares Foundation Patient Assistance Program

Alunbrig (brigatinib) Tablets

Drug company: Takeda Oncology
844-817-6468

Takeda Oncology offers 2 financial assistance programs for patients using Alunbrig:

Takeda Oncology Co-Pay Assistance Program

Takeda Oncology Patient Assistance Program

Augtyro (repotrectinib)

Drug company: Bristol Myers Squibb
800-861-0048

Bristol Myers Squibb offers 1 financial assistance program for patients using Augtyro:

Bristol Myers Squibb Access Support

Avastin (bevacizumab) Injection

Drug company: Genentech
866-422-2377

Genentech Oncology offers 2 financial assistance programs for patients using Avastin:

Genentech Oncology Co-pay Assistance Program

Genentech Patient Foundation

Braftovi (encorafenib) Capsules

Drug company: Pfizer
877-744-5675

Pfizer Oncology Together offers 2 financial assistance programs for patients who have been prescribed Braftovi:

Co-Pay Assistance Program

Pfizer Patient Assistance Program

Cosela (trilaciclib) Injection

Drug company: G1 Therapeutics
833-418-6663

G1 Therapeutics offers 2 financial assistance programs for patients using Cosela:

G1 Commercial Copay Program

Patient Support Program

Cyramza (ramucirumab) Injection

Drug company: Eli Lilly
866-472-8663

Lilly Oncology offers 2 financial assistance programs for patients using Cyramza:

Cyramza Savings Card

Lilly Cares Foundation Patient Assistance Program

Enhertu (fam-trastuzumab deruxtecan-nxki) Injection

Drug company: Daiichi Sankyo/AstraZeneca
833-364-3788

Daiichi Sankyo and AstraZeneca offer 2 patient assistance programs for patients using Enhertu:

Enhertu Patient Savings Program

Enhertu Patient Assistance Program

Exkivity (mobocertinib) Capsules

Drug company: Takeda Oncology
844-817-6468

Takeda Oncology offers 2 financial assistance programs for patients using Exkivity:

Takeda Oncology Co-Pay Assistance Program

Takeda Oncology Patient Assistance Program

Gavreto (pralsetinib) Capsules

Drug company: Genentech
866-422-4377

Genentech Access Solutions offers 2 financial assistance programs for patients who have been prescribed Gavreto:

Genentech Oncology Co-pay Assistance Program

Genentech Patient Foundation

Gilotrif (afatinib) Tablets

Drug company: Boehringer Ingelheim
844-569-2836

Boehringer Ingelheim offers 4 financial assistance programs for patients using Gilotrif.

Gilotrif Plus Co-pay Assistance Program

Gilotrif Bridge Program

Gilotrif Dose Exchange Program

BI Cares Foundation Patient Assistance Program

Hycamtin (topotecan)

Drug company: Novartis
800-282-7630

Novartis Patient Assistance NOW Oncology offers 2 financial assistance program for patients using Hycamtin:

Novartis Patient Assistance Foundation

Patient Assistance Now Oncology

Imjudo (tremelimumab) & Imfinzi (durvalumab)

Drug company: AstraZeneca
844-275-2360

AstraZeneca Access 360 offers 2 financial assistance programs for patients using Imfinzi:

Imfinzi Co-pay Savings Program

AZ&Me Prescription Savings Program

Imfinzi (durvalumab)

Drug company: AstraZeneca
844-275-2360

AstraZeneca Access 360 offers 2 financial assistance programs for patients using Imfinzi:

Imfinzi Co-pay Savings Program

AZ&Me Prescription Savings Program

Iressa (gefitinib) Tablets

Drug company: AstraZeneca
844-275-2360

AstraZeneca Access 360 offers 2 financial assistance programs for patients using Iressa:

IRESSA Co-pay Savings Program

AZ&Me Prescription Savings Program

Keytruda (pembrolizumab)

Drug company: Merck
855-257-3932

Merck offers 2 financial assistance programs for patients using Keytruda:

Merck Co-pay Assistance Program

Merck Patient Assistance Program

Krazati (adagrasib)

Drug company: Mirati Therapeutics
844-647-2842

Mirati Therapeutics offers 1 financial assistance program for patients using Krazati:

Mirati & Me

Libtayo (cemiplimab-rwlc) Injection

Drug company: Regeneron/Sanofi Genzyme
877-542-8296

Regeneron and Sanofi Genzyme, through Libtayo Surround, offer 2 financial assistance programs for patients who have been prescribed Libtayo:

Libtayo Surround Commercial Copay Program

Libtayo Surround Patient Assistance Program

Lorbrena (lorlatinib) Tablets

Drug company: Pfizer
877-744-5675

Pfizer Oncology Together offers 2 financial assistance programs for patients who have been prescribed Lorbrena:

Pfizer Oncology Together Co-Pay Savings Program

Pfizer Patient Assistance Program

Lumakras (sotorasib) Tablets

Drug company: Amgen
888-427-7478

Amgen Assist 360 offers 2 financial assistance programs for patients using Lumakras:

Amgen FIRST STEP Co-Pay Program

Amgen Safety Net Foundation

Mekinist (trametinib) & Tafinlar (dabrafenib)

Drug company: Novartis
800-282-7630

Novartis Patient Assistance NOW Oncology offers 3 financial assistance programs for patients using the combination of Mekinist and Tafinlar:

Novartis Oncology Universal Co-pay Program

Patient Assistance Now Oncology

Novartis Patient Assistance Foundation

Mvasi (bevacizumab-awwb)

Drug company: Amgen
888-427-7478

Amgen Assist 360 offers 2 financial assistance programs for patients who have been prescribed Mvasi:

Amgen FIRST STEP Co-Pay Program

Amgen Safety Net Foundation

Opdivo (nivolumab)

Drug company: Bristol Myers Squibb
800-861-0048

Bristol Myers Squibb Access Support provides 2 financial assistance programs for patients using Opdivo:

BMS Oncology Co-Pay Assistance Program

Bristol Myers Squibb Patient Assistance Foundation

Photofrin (porfimer)

Drug company: Pinnacle Biologics
855-215-2720

Pinnacle Biologics offers 1 financial assistance program for patients using Photofrin:

Photofrin Patient Assistance Program

Portrazza (necitumumab)

Drug company: Eli Lilly
866-472-8663

Lilly Oncology offers 1 financial assistance program for patients using Portrazza:

Lilly Cares Foundation Patient Assistance Program

Retevmo (selpercatinib) Capsules

Drug company: Eli Lilly
866-472-8663

Lilly Oncology offers 2 financial assistance programs for patients who have been prescribed Retevmo:

Retevmo Savings Card

Lilly Cares Foundation Patient Assistance Program

Rozlytrek (entrectinib) Capsules

Drug company: Genentech
866-422-2377

Genentech Oncology offers 2 financial assistance programs for patients who have been prescribed Rozlytrek:

Genentech Oncology Co-pay Assistance Program

Genentech Patient Foundation

Rybrevant (amivantamab-vmjw) Injection

Drug company: Janssen Biotech
833-792-7382

Janssen Biotech, through Janssen CarePath, offers 1 financial assistance program for patients using Rybrevant:

Janssen CarePath Savings Program

Tabrecta (capmatinib) Tablets

Drug company: Novartis
800-282-7630

Novartis Patient Assistance NOW Oncology offers 4 financial assistance programs for patients who have been prescribed Tabrecta:

Novartis Oncology Universal Co-pay Program

Patient Assistance Now Oncology

Novartis Patient Assistance Foundation

Tabrecta 14-Day Free Trial Program

Tagrisso (osimertinib) Tablets

Drug company: AstraZeneca
844-275-2360

AstraZeneca Access 360 offers 2 financial assistance programs for patients using Tagrisso:

Tagrisso Co-pay Savings Program

AZ&Me Prescription Savings Program

Tarceva (erlotinib) Tablets

Drug company: Genentech
866-422-2377

Genentech Oncology offers 2 financial assistance programs for patients using Tarceva:

Genentech Oncology Co-pay Assistance Program

Genentech Patient Foundation

Tecentriq (atezolizumab)

Drug company: Genentech
866-422-2377

Genentech Oncology offers 2 financial assistance programs for patients using Tecentriq:

Genentech Oncology Co-pay Assistance Program

Genentech Patient Foundation

Tepmetko (tepotinib) Tablets

Drug company: EMD Serono
844-662-3631

EMD Serono offers 3 financial assistance programs for patients using Tepmetko:

ONC Co-Pay Assistance Program

ONC Patient Assistance Program

Bridge Program

Vizimpro (dacomitinib) Tablets

Drug company: Pfizer
877-744-5675

Pfizer Oncology Together offers 2 financial assistance programs for patients who have been prescribed Vizimpro:

Pfizer Oncology Together Co-Pay Savings Program

Pfizer Patient Assistance Program

Xalkori (crizotinib) Capsules

Drug company: Pfizer
877-744-5675

Pfizer Oncology Together offers 2 financial assistance programs for patients using Xalkori:

Pfizer Oncology Together Co-Pay Savings Program

Pfizer Patient Assistance Program

Yervoy (ipilimumab)

Drug company: Bristol Myers Squibb
800-861-0048

Bristol Myers Squibb Access Support offers 2 financial assistance programs for patients who have been prescribed Yervoy:

BMS Oncology Co-pay Assistance Program

Bristol Myers Squibb Patient Assistance Foundation

Zepzelca (lurbinectedin) Injection

Drug company: Jazz Pharmaceuticals
833-533-5299

JazzCares offers 2 financial assistance programs for patients who have been prescribed Zepzelca:

JazzCares Copay Savings Card

JazzCares Patient Assistance Program

Zirabev (bevacizumab-bvzr)

Drug company: Pfizer
877-744-5675

Pfizer Oncology Together offers 2 financial assistance programs for patients who have been prescribed Zirabev:

Pfizer Oncology Together Co-Pay Savings Program

Pfizer Patient Assistance Program

Zykadia (ceritinib) Capsules

Drug company: Novartis
800-282-7630

Novartis Patient Assistance NOW Oncology offers 3 financial assistance programs for patients using Zykadia:

Patient Assistance Now Oncology

Novartis Oncology Universal Co-pay Program

Novartis Patient Assistance Foundation